Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cholesterol Self-testing in Patients Post Acute Coronary Syndrome
Sponsor: University of Leipzig
Summary
The pharmacological reduction of LDL-C lowers cardiovascular risk and is therefore a priority in cardiovascular secondary prevention. The achievement of LDL-C target levels in Germany, Europe, and worldwide is inadequate, despite a wide array of lipid-lowering medications. Only a small proportion of post-myocardial infarction patients reach their LDL-C target range within a year. There is a significant need for new strategies to improve LDL-C target achievement and thereby reduce the occurrence of secondary cardiovascular events. The aim of the study is to establish a basis for improving prevention by achieving the target LDL level effectively and quickly in patients with high and very high cardiovascular risk profiles.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-06-01
Completion Date
2025-09-30
Last Updated
2024-08-01
Healthy Volunteers
No
Interventions
Cholesterol self-measurement
Patients will be trained to use a device to self-measurement of cholesterol-values monthly. After the measurement they will report their results to study team for ajusting the therapy.
Locations (1)
Clinic of cardiology University clinic Leipzig
Leipzig, Saxony, Germany